Infectious Diseases Service, University Hospital of Lausanne, Lausanne, Switzerland.
Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St.Gallen, St.Gallen, Switzerland.
BMC Infect Dis. 2023 Sep 26;23(1):630. doi: 10.1186/s12879-023-08630-0.
A prospective observational cohort study of COVID-19 patients in a single Emergency Department (ED) showed that sTREM-1- and IL-6-based algorithms were highly predictive of adverse outcome (Van Singer et al. J Allergy Clin Immunol 2021). We aim to validate the performance of these algorithms at ED presentation.
This multicentric prospective observational study of PCR-confirmed COVID-19 adult patients was conducted in the ED of three Swiss hospitals. Data of the three centers were retrospectively completed and merged. We determined the predictive accuracy of the sTREM-1-based algorithm for 30-day intubation/mortality. We also determined the performance of the IL-6-based algorithm using data from one center for 30-day oxygen requirement.
373 patients were included in the validation cohort, 139 (37%) in Lausanne, 93 (25%) in St.Gallen and 141 (38%) in EOC. Overall, 18% (93/373) patients died or were intubated by day 30. In Lausanne, 66% (92/139) patients required oxygen by day 30. The predictive accuracy of sTREM-1 and IL-6 were similar compared to the derivation cohort. The sTREM-1-based algorithm confirmed excellent sensitivity (90% versus 100% in the derivation cohort) and negative predictive value (94% versus 100%) for 30-day intubation/mortality. The IL-6-based algorithm performance was acceptable with a sensitivity of 85% versus 98% in the derivation cohort and a negative predictive value of 60% versus 92%.
The sTREM-1 algorithm demonstrated good reproducibility. A prospective randomized controlled trial, comparing outcomes with and without the algorithm, is necessary to assess its safety and impact on hospital and ICU admission rates. The IL-6 algorithm showed acceptable validity in a single center and need additional validation before widespread implementation.
一项针对单一急诊科(ED)的 COVID-19 患者的前瞻性观察队列研究表明,sTREM-1 和 IL-6 为基础的算法对不良结局具有高度预测性(Van Singer 等人,J Allergy Clin Immunol 2021)。我们旨在验证这些算法在 ED 就诊时的表现。
这项针对 PCR 确诊的 COVID-19 成年患者的多中心前瞻性观察性研究在瑞士三家医院的 ED 进行。三个中心的数据进行了回顾性补充并合并。我们确定了 sTREM-1 为基础的算法对 30 天插管/死亡率的预测准确性。我们还使用一个中心的数据确定了基于 IL-6 的算法对 30 天氧气需求的性能。
373 例患者纳入验证队列,其中 139 例(37%)来自洛桑,93 例(25%)来自圣加仑,141 例(38%)来自 EOC。总体而言,18%(93/373)的患者在第 30 天死亡或插管。在洛桑,66%(92/139)的患者在第 30 天需要吸氧。sTREM-1 和 IL-6 的预测准确性与推导队列相似。sTREM-1 为基础的算法对 30 天插管/死亡率的敏感性(推导队列为 90%,验证队列为 100%)和阴性预测值(推导队列为 94%,验证队列为 100%)均良好。IL-6 为基础的算法的性能可接受,其在推导队列中的敏感性为 85%,阴性预测值为 60%,在验证队列中的敏感性为 98%,阴性预测值为 60%。
sTREM-1 算法具有良好的可重复性。需要一项前瞻性随机对照试验,比较有无算法的结果,以评估其安全性和对医院和 ICU 入院率的影响。IL-6 算法在单个中心表现可接受,需要进一步验证,然后再广泛实施。